AC IMMUNE SA SF-02 (IMR) — Tangible Net Worth Ratio
AC IMMUNE SA SF-02 (IMR) has a Tangible Net Worth Ratio of -43.4% as of June 2026. This metric is calculated by deducting intangible assets (€50.42 Million) from net assets (€35.17 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore IMR net assets growth trend to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
AC IMMUNE SA SF-02 Tangible Net Worth Ratio (2021–2025)
This chart shows how AC IMMUNE SA SF-02's Tangible Net Worth Ratio has changed across 5 annual periods from 2021 to 2025. As of June 2026, the ratio stands at -43.4%, reflecting net assets of €35.17 Million with intangible assets of €50.42 Million EUR. For live market cap and overall valuation, see market value of AC IMMUNE SA SF-02.
Annual Tangible Net Worth Ratio for AC IMMUNE SA SF-02 (2021–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for AC IMMUNE SA SF-02 from 2021 to 2025, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore AC IMMUNE SA SF-02 capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -12.3% | €44.88 Million | €50.42 Million | €154.25 Million | ▼ -67.4 pp |
| 2024 | 55.1% | €112.27 Million | €50.42 Million | €230.91 Million | ▼ -13.5 pp |
| 2023 | 68.6% | €160.64 Million | €50.42 Million | €182.81 Million | ▼ -1.6 pp |
| 2022 | 70.2% | €168.99 Million | €50.42 Million | €185.94 Million | ▼ -8.1 pp |
| 2021 | 78.3% | €231.98 Million | €50.42 Million | €261.44 Million | — |